Search

everythinglearnresearchcommunity

for

Search:↓

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

The European School of Oncology organized various educational events in 1994, highlighting important cancer research findings.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Etoposide is effective in treating several cancers, especially small cell lung cancer, with acceptable side effects.

A specific ATR gene mutation is linked to a hereditary oropharyngeal cancer syndrome.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

Newly made nicotinamide compounds could potentially treat cancer.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

The revised study on how inflammation affects cancer stem cells was accepted after improving clarity and structure.

The revised manuscript on how inflammation affects cancer stem cells was accepted after addressing issues with clarity and detail.

Chemotherapy often causes hair loss in cancer patients, affecting their mental health, but scalp cooling can help prevent it.

Correct testosterone levels for age to treat prostate cancer, using low dose treatments as necessary.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Blocking the Wnt pathway could lead to new treatments for cancer and tissue repair but requires careful development to avoid side effects.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Enhancers and super-enhancers are key in controlling specific gene activity and can play a role in cancer development.

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.

The reviewers found the manuscript on inflammation's role in cancer stem cells to be relevant but suggested it needs clarity, more background information, discussion on immune cells' role in tumors, updated references, and grammar corrections.

Docetaxel is safe and works well for older people with cancer, with manageable side effects.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

The reviewers suggest clarifying the abstract, adding background on inflammation's effect on stem cells and cancer, discussing immune cells' role in tumors, and considering inflammation's potential to reduce cancer growth.

The reviewers suggest clarifying and expanding on the role of inflammation in stem cell-related cancer development.

The reviewers suggest major revisions for clarity and inclusion of recent findings on inflammation's role in cancer.

Reviewers suggest clarifying the abstract, adding background on inflammation's effect on cancer, discussing immune cell roles, including counter studies, and correcting grammar.

Most non-medical students at Tarumanagara University have good knowledge and attitudes about PCOS.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.